Komori
Soiken Holdings (2385) · InitiativeAdvanced

Transition to an E-Commerce Business Supporting Self-Medication

First written in FY2025. 3 of 4 entries say "Advanced", first in 2026-08-12. Latest entry: FY2026.

4entries
2years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2025Advanced2026-08-12 – FY20262025: 120252026: 32026
Same theme, other companies
Three-business structure spanning healthcare, medical care and marketingA theme 4 companies write about · 0 as a headwind · 5 as a tailwind

1 other company's latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「Using an e-commerce site for self-medication products, including health supplements and cosmetics, OTC medicines and Kampo medicines, and mail-in testing as its foundation, we are building an “integrated healthcare platform” that combines online medical consultations, an online pharmacy and second-opinion services to provide services seamlessly from prevention through treatment.」

    The vision has evolved from mail-order sales centered on Imida Peptide into a mail-order business supporting self-medication that combines OTC medicines, Kampo medicines, mail-in testing, online medical consultations and online pharmacies.
  3. FY2025First statedAnnual report

    「The Company plans to strengthen this business as a mail-order business supporting self-medication, centered on its core anti-fatigue ingredient Imida Peptide, while successively introducing new self-medication products such as OTC medicines, quasi-drugs and Kampo medicines to diversify its product portfolio.」

    The Company has newly stated a policy of expanding the Imida Peptide-centered health supplements business into a mail-order business supporting self-medication by adding OTC medicines, quasi-drugs, Kampo medicines and other products.
Moved together

"Building an Integrated Healthcare Platform Centered on Medical DX" moved the same way as this thread, in the same document, in 3 of its 4 moves.

332222★123456
  1. ★This thread
  2. 1Building an Integrated Healthcare Platform Centered on Medical DX3×
  3. 2Ending the Cosmetics Subsidiary's Business Activities and Transferring the Domestic Placenta Business3×
  4. 3Transforming the Business Structure From Food Development Support to Proprietary Products and Evidence Support2×
  5. 4Recovery and Expansion of Business Performance2×
  6. 5Expanding the Healthcare Support Business and Generating Operating Profit Consistently2×
  7. 6Building a Stable Earnings Base and Resuming Dividends2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Soiken Holdings yet. It last moved in the Timely disclosure of 2026-08-12: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.